论文部分内容阅读
为了确定重组白细胞A干扰素(γIFN-2A)抗鼻病毒攻击的可耐受的有效剂量,作者用13型鼻病毒(RV13)攻击56名健康志愿者后,随机分组给予安慰剂和γIFN-2A(2.4×10~6U或0.7×10~6U/天).实验结果表明,2.4×10~6U剂量组的发
To determine the tolerable effective dose of rhIFN-2A against rhinoviral challenge, the authors randomized 56 healthy volunteers to type 13 rhinovirus (RV13) to placebo and γIFN-2A (2.4 × 10 ~ 6U or 0.7 × 10 ~ 6U / day) .Experimental results show that, 2.4 × 10 ~ 6U dose group hair